_

The Scoop On Smoking from ACSH: what every teen should know about tobacco

what every teen should know about tobacco

quitting references

  1. Centers for Disease Control and Prevention. Cigarette Smoking Among Adults -- United States, 2000. Morbidity and Mortality Weekly Report. 2002;51:642-645.
  2. U.S. Department of Health and Human Services. Health Benefits of Smoking Cessation. A Report of the US Surgeon General. Rockville, MD: National Institute on Drug Abuse, 1990.
  3. Burns DM, Anderson C, Major J, Vaughn J, Shanks T. Cessation and cessation measures among adult daily smokers: National and state-specific data. In: Population Impact of Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population: Smoking and Tobacco Control Monograph No. 12. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Pub. No. 00-4892, November 2000;25-98.
  4. Fiore MC, Novotny TE, Pierce JP, et al. Methods used to quit smoking in the United States. JAMA. 1990;263:2760-2765.
  5. Hughes JR, Burns D. Impact of medications on smoking cessation. In: Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population. Smoking and Tobacco Control Monograph No. 12. Bethesda, MD: U.S. Departments of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Pub. No. 00-4892, November 2000;155-164.
  6. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence, Clinical Practice Guideline. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, 2000.
  7. American Lung Association. What are the benefits of quitting smoking? Available at http://www.lungusa.org/tobacco/quit_ben.html. Accessed January 29, 2002.
  8. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med. 1985;313:1511-1514.
  9. Tverdal A, Thelle D, Stensvold I, et al. Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years. J Clin Epidemiol. 1993;46:475-487.
  10. Samet JM. The health benefits of smoking cessation. Med Clin North Am. 1992;76:39-414.
  11. Peto R. Influence of dose and duration of smoking on lung cancer rates. In: Zaridze D, Peto R, eds. Tobacco: A Major International Health Hazard. Lyon: ARC Scientific Publications No. 74, 1996;23-33.
  12. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. British Medical Journal. 2002;325:188-191.
  13. U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, GA: U.S. Office on Smoking and Health, 2000.
  14. U.S. Dept Health and Human Services. Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Washington: U.S. Government Printing Office, 1994.
  15. Sweanor D, Burns DM, Major JM, Anderson CM. Effect of cost on cessation. In: Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population, Smoking and Tobacco Control Monograph No. 12. Rockville, MD: National Institute on Drug Abuse, November 2000;165-178.
  16. Schauffler HH, Barker DC, Orleans TC. State Report: Medicaid Coverage for Tobacco-dependence. Health Affairs, 2001;20(1):298-303.
  17. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs -- United States, 1995-1999. Morbidity and Mortality Weekly Report. 51(14):300-303, April 2002.
  18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition. Washington: American Psychiatric Association, 1994.
  19. Hughes JR. Psychiatric comorbidity. Nicotine Tob Res. 1999;1:S149-152.
  20. Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Hlth Psychol. 1992;11:331-334.
  21. West RJ. The 'nicotine replacement paradox' in smoking cessation. How does nicotine gum really work? Br J Addict. 1992;87:16-167.
  22. Hughes JR. Dependence on and abuse of nicotine replacement medications: An update. In: Benowitz NL, ed. Nicotine Safety & Toxicity. New York: Oxford Press, 1998;147-157.
  23. Benowitz NL. Nicotine Safety and Toxicity. New York: Oxford University Press, 1998.
  24. Benowitz NL, Dempsey DA, Goldenberg RL, et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control 2000;9:iii91-iii94.
  25. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:1422-1431.
  26. Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in pharmacotherapy of smoking. JAMA. 1999;281:72-76.
  27. Fiore MC. U.S. Public Health Service clinical practice guideline: treating tobacco use and dependence. Respir Care. 2000;45:1200-1262.
  28. The Nicotine Inhaler. Available at: http://www.quitnet.com/Library/Guides/NRT/inhaler.jtml. Accessed January 20, 2002.
  29. The Nicotine Inhaler. Available at: http://www.quitnet.com/Library/Gides/NRT/Inhaler_specifics.jtml. Accessed January 20, 2002.
  30. http://content.health.msn.com/content/article/53/61384.htm
  31. http://www.fda.gov/bbs/topics/NEWS/2002/NEW00818.html
  32. http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01144.html
  33. Okuyemi KS, Ahluwalia JS, Harris KJ, et al. Pharmacotherapy of smoking cessation. Arch Fam Med. 2000;9:270-281.
  34. Hays JT, Wolter TD, Eberman KM, et al. Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clin Proc. 2001;76:124-133.
  35. Bupropion (Wellbutrin/Zyban). Available at: http://www.quitnet.com/Library/Guides/NRT/bupropion.jtml. Accessed January 29, 2002.
  36. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340:685-691.
  37. Jamerson BD, Nides M, Jorenby DE, et al. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clin Ther. May 2001;23(5):744-52.
  38. Quitting Guide. Getting Ready. Available at: http://www.quitnet.com/library/guides/Quitnet/B/getting_ready.jtml:whyquittingishard. Accessed July 16, 2002.
  39. Hughes JR. Pharmacotherapy for smoking cessation: Unvalidated assumptions, anomalies, and suggestions for further research. J Consult Clin Psychol. 1993;61:751-760.
  40. Karnath B. Smoking cessation. The American Journal of Medicine. 2002;112:399-405.
  41. Lichtenstein E, Glasgow RE, Lando HA, Ossip-Klein DJ. Telephone counseling for smoking cessation: Rationales and review of evidence. Hlth Educ Res. 1996;11:243-257.
  42. Zhu SH, Anderson CM, Tedeschi GJ, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002;347:1087-1093.
  43. Lancaster T, Stead LF. Self-help interventions for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 3 2002. Oxford: Update Software.
  44. Irvin JE, Brandon TH. The increasing recalcitrance of smokers in clinical trials. Nicotine. Tob Res. 2000;2:79-84.
  45. Hays JT, Wolter TD, Eberman KM, et al. Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clin Proc. 2001;76:124-133.
  46. Hall W. The prospects for immunotherapy in smoking cessation. Lancet. 2002;360:1089-91.
  47. Pentel P, Malin D. A vaccine for nicotine dependence: targeting the drug rather than the brain. Respiration. 2002;69:193-197.
  48. Lindblom N, de Villiers SH, Kalayanov G, et al. Active immunization against nicotine prevents reinstatement of nicotine-seeking behaviour in rats. Respiration. 2002;69:254-60.
  49. Xenova Group plc: Successful Results of Phase I Trial for TA-NIC -- First Evaluation of Anti-Nicotine Vaccine in Man. Available at http://www.xenova.co.uk/PressReleases/pr_2000614_01.html. Accessed September 3, 2002.
  50. VRIPTECH International. Available at: http://www.vriptech.com/qa.htm. Accessed December 3, 2002.
  51. Williamson DF, Madans J, Anda RF, et al. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med. 1991;34:739-745.
  52. Rigotti NA. Treatment options for the weight-conscious smoker. Arch Intern Med. 1999;159:1169-1171.
  53. Perkins KA. Weight gain following smoking cessation. J Consult Clin Psychol. 1993;61:768-777.
  54. Marcus BH, Albrecht AE, King TK, et al. The efficacy of exercise as an aid for smoking cessation in women: randomized controlled trial. Arch Intern Med. 1999;159:1229-1234.
  55. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: A causal analysis. Archives of General Psychiatry. 1993;50:36-43.
  56. Borrelli B, Niaura R, Keuthen NJ, Goldstein MG, DePue JD, Murphy C, Abrams DB. Development of major depressive disorder during smoking-cessation treatment. Journal of Clinical Psychiatry. 1996;57(11):534-538.
  57. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001;357:1929-1932.
  58. National Institute on Alcohol Abuse and Alcoholism. Alcohol Alerts. No 30: Alcohol and Tobacco. Available at: http://www.niaa.nih.gov/publications/aa39.itml. Accessed: July 12, 2002.
  59. Giovino GA, Henningfield, JE, Tomar SL, Escobedo LG, and Slade J. Epidemiology of Tobacco Use and Dependence. (1995). Epidemiology Review. 17;48-65.
  60. Perkins, KA. Smoking cessation in women. Special considerations. CNS Drugs. 2001;15:391-411.
  61. Sussman S, Lichtman K, Ritt A, Pallonen UE. Effects of thirty-four adolescent tobacco use cessation and prevention trials on regular users of tobacco products. Subst Use Misuse. 1999;34(11):1469-1503.
  62. Schauffler HH, Parkinson, MD. Health insurance coverage for smoking cessation services. Health Educ Q. 1993;20:185-206.
  63. Curry SJ, Grothaus LC, McAfee T, Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med. 1998;339:673-679.
  64. Centers for Disease Control and Prevention. Update on state Medicaid coverage for tobacco dependence treatments -- United States, 1998 and 2000. Morbidity and Mortality Weekly Report. 2001;50(40):979-982.
  65. Nicotine replacement for smokers. The Lancet. 2001;357:897.
  66. Shiffman S, Pinney JM, Gitchell J, Burton SL, Lara EA. Public health benefit of over-the-counter nicotine medications. Tob Control 1997;306-310.
  67. Shiffman S, Rolf CN, Hellebusch SJ, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction. 2002;97(5):505-16.
  68. Warner KE, Luce BR. Cost-Benefit and Cost-Effectiveness Analyses in Health Care: Principles, Practice, and Potential. Ann Arbor: Health Administration Press, 1983.
  69. Pingree S, Boberg E, Patten C, et al. Helping adolescents quit smoking: a needs assessment of current and former teen smokers. Health Communication. 2004;16(2):185-94.

The American Council on Science and Health is a consumer eduction consortium with a board of 350 physicians, scientists, and policy advisors.

Valid XHTML 1.0! Valid CSS!